Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Mar;16(3):376-389.
doi: 10.1016/j.jcmg.2022.12.029.

Diagnostic and Prognostic Role of Cardiac Magnetic Resonance in MINOCA: Systematic Review and Meta-Analysis

Niya Mileva  1 , Pasquale Paolisso  2 , Emanuele Gallinoro  3 , Davide Fabbricatore  4 , Daniel Munhoz  5 , Luca Bergamaschi  6 , Marta Belmonte  4 , Panayot Panayotov  7 , Carmine Pizzi  6 , Emanuele Barbato  8 , Martin Penicka  3 , Daniele Andreini  9 , Dobrin Vassilev  10
Affiliations
Free article
Meta-Analysis

Diagnostic and Prognostic Role of Cardiac Magnetic Resonance in MINOCA: Systematic Review and Meta-Analysis

Niya Mileva et al. JACC Cardiovasc Imaging. 2023 Mar.
Free article

Abstract

Background: Myocardial infarction with nonobstructive coronary arteries (MINOCA) is common in current clinical practice. Cardiac magnetic resonance (CMR) plays an important role in its management and is increasingly recommended by all the current guidelines. However, the prognostic value of CMR in patients with MINOCA is still undetermined.

Objectives: The purpose of this study was to determine the diagnostic and prognostic value of CMR in the management of patients with MINOCA.

Methods: A systematic review was performed to identify studies reporting the results of CMR findings in patients with MINOCA. Random effects models were used to determine the prevalence of different disease entities: myocarditis, myocardial infarction (MI), or takotsubo syndrome. Pooled odds ratios (ORs) and 95% CIs were calculated to evaluate the prognostic value of CMR diagnosis in the subgroup of studies that reported clinical outcomes.

Results: A total of 26 studies comprising 3,624 patients were included. The mean age was 54.2 ± 5.3 years, and 56% were men. MINOCA was confirmed in only 22% (95% CI: 0.17-0.26) of the cases and 68% of patients with initial MINOCA were reclassified after the CMR assessment. The pooled prevalence of myocarditis was 31% (95% CI: 0.25-0.39), and takotsubo syndrome 10% (95% CI: 0.06-0.12). In a subgroup analysis of 5 studies (770 patients) that reported clinical outcomes, CMR diagnosis of confirmed MI was associated with an increased risk of major adverse cardiovascular events (pooled OR: 2.40; 95% CI: 1.60-3.59).

Conclusions: In patients with MINOCA, CMR has been demonstrated to add an important diagnostic and prognostic value, proving to be crucial for the diagnosis of this condition. Sixty-eight percent of patients with initial MINOCA were reclassified after the CMR evaluation. CMR-confirmed diagnosis of MINOCA was associated with an increased risk of major adverse cardiovascular events at follow-up.

Keywords: cardiac magnetic resonance; late-gadolinium enhancement; myocardial infarction; nonobstructive coronary artery disease.

PubMed Disclaimer

Conflict of interest statement

Funding Support and Author Disclosures Dr Mileva has received speaker fees from Abbott. Drs Paolisso, Fabbricatore, and Munhoz have received research grants provided by the Cardiopath PhD program. Dr Andreini has received research grants from GE Healthcare and Bracco. Dr Marta Belmonte has received a research grant from the Cardiopath PhD program. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Comment in

  • MINOCA and CMR: Where Do We Stand?
    Leo I, Bucciarelli-Ducci C. Leo I, et al. JACC Cardiovasc Imaging. 2023 Jul;16(7):996. doi: 10.1016/j.jcmg.2023.03.027. JACC Cardiovasc Imaging. 2023. PMID: 37407129 No abstract available.
  • Reply: MINOCA and CMR: Where Do We Stand?
    Mileva N, Bergamaschi L, Paolisso P, Pizzi C, Vassilev D. Mileva N, et al. JACC Cardiovasc Imaging. 2023 Jul;16(7):997. doi: 10.1016/j.jcmg.2023.05.014. JACC Cardiovasc Imaging. 2023. PMID: 37407130 No abstract available.

MeSH terms

LinkOut - more resources